CoChat

SWI/SNF regulates a transcriptional program that induces senescence to prevent liver cancer

Open access
Tordella, Luca, Khan, Sadaf, Hohmeyer, Anja, Banito, Ana, Klotz, Sabrina, Raguz, Selina, Martin, Nadine, Dhamarlingam, Gopuraja, Carroll, Thomas, González Meljem, José Mario, Deswal, Sumit, Martínez-Barbera, Juan Pedro, García-Escudero, Ramón, Zuber, Johannes, Zender, Lars, Gil, Jesús · 2016 · Genes & Development
Cited by 58

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Oncogene-induced senescence (OIS) is a potent tumor suppressor mechanism. To identify senescence regulators relevant to cancer, we screened an shRNA library targeting genes deleted in hepatocellular carcinoma (HCC). Here, we describe how knockdown of the SWI/SNF component ARID1B prevents OIS and cooperates with RAS to induce liver tumors. ARID1B controls p16 INK4a and p21 CIP1a transcription but also regulates DNA damage, oxidative stress, and p53 induction, suggesting that SWI/SNF uses additional mechanisms to regulate senescence. To systematically identify SWI/SNF targets regulating senescence, we carried out a focused shRNA screen. We discovered several new senescence regulators, including ENTPD7, an enzyme that hydrolyses nucleotides. ENTPD7 affects oxidative stress, DNA damage, and senescence. Importantly, expression of ENTPD7 or inhibition of nucleotide synthesis in ARID1B-depleted cells results in re-establishment of senescence. Our results identify novel mechanisms by which epigenetic regulators can affect tumor progression and suggest that prosenescence therapies could be employed against SWI/SNF-mutated cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.286112.116

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. 10.1016/j.tcb.2011.11.006 · DOI · Paper page
  2. 1962, Effects of 6-diazo-5-oxo-L-norleucine on the incorporation of precursors into nucleic acids, Cancer Res, 22, 908
  3. 2015, Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers, Nat Med, 21, 231, 10.1038/nm.3799 · DOI · Paper page
  4. 10.1073/pnas.1009559107 · DOI · Paper page
  5. 10.1158/0008-5472.CAN-05-1896 · DOI · Paper page
  6. 10.1038/8811 · DOI · Paper page
  7. 10.1038/ncb2038 · DOI · Paper page
  8. 10.1016/j.celrep.2013.11.020 · DOI · Paper page
  9. 10.1038/ng.2291 · DOI · Paper page
  10. 10.1158/0008-5472.CAN-11-1562 · DOI · Paper page
  11. 10.1016/j.cell.2011.02.013 · DOI · Paper page
  12. 10.1016/j.ccr.2014.07.018 · DOI · Paper page
  13. 10.1038/nm.3480 · DOI · Paper page
  14. 10.1038/ng.2628 · DOI · Paper page
  15. 10.1038/bjc.2013.200 · DOI · Paper page
  16. 10.1128/MCB.02019-07 · DOI · Paper page
  17. 10.1074/jbc.M111987200 · DOI · Paper page
  18. 10.1186/s13148-015-0091-3 · DOI
  19. 10.1038/nm0905-920 · DOI
  20. 10.1074/jbc.M309333200 · DOI · Paper page
  21. 10.1038/nrg3554 · DOI · Paper page
  22. 10.1007/s11302-006-9003-5 · DOI · Paper page
  23. 10.18632/oncotarget.2092 · DOI · Paper page
  24. 10.1038/ng.2493 · DOI · Paper page
  25. 10.1371/journal.pone.0055119 · DOI · Paper page
  26. 10.1074/jbc.M011569200 · DOI
  27. 10.1073/pnas.94.21.11268 · DOI · Paper page
  28. 10.1021/bi901588z · DOI
  29. 10.1038/nrg3539 · DOI · Paper page
  30. 10.1038/nrc3068 · DOI · Paper page
  31. 10.1016/j.cell.2008.09.061 · DOI · Paper page

Cited by

See all 58

Metadata

Authors
Tordella, L., Khan, S., Hohmeyer, A., Banito, A., Klotz, S., Raguz, S., Martin, N., Dhamarlingam, G., Carroll, T., González Meljem, J. M., Deswal, S., Martínez-Barbera, J. P., García-Escudero, R., Zuber, J., Zender, L., & Gil, J.
Venue
Genes & Development
Published
2016-10-01
Volume
30
Issue
19
Pages
2187-2198
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2530620398
Cited by
58
References
14
Type
posted content
Language
en
Open access
diamond
Funders
  • Medical Research Council (Centenary Award, MC-A652-5PZ00, MC_U120085810)
  • Instituto de Salud Carlos III-Redes Temáticas de Investigación Cooperativa en Salud (RD12/0036/0009)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.